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InﬂammationTrypanosoma cruzi (T. cruzi), the etiological agent of Chagas' disease, causes cardiac alterations in the host.
Although the main clinical manifestations arise during the chronic stage, the mechanisms leading to heart
damage develop early during infection. In fact, an intense inﬂammatory response is observed from acute
stage of infection. Recently, peroxisome proliferator-activated receptors (PPARs) have attracted research
interest due to their participation in the modulation of inﬂammation. In this work we addressed the role of
15-Deoxy-Δ12,14 ProstaglandinJ2 (15dPGJ2), a PPARγ natural ligand in the regulation of inﬂammatory
mediators, in acute and chronic experimental mouse models of Chagas' disease with the RA and K98 T. cruzi
strains, respectively. This work demonstrates that 15dPGJ2 treatment inhibits the expression and activity of
inducible nitric oxide synthase (NOS2) as well as TNF-α and IL-6 mRNA levels. Also, expression and activity
of metalloproteinases 2 (MMP-2) and 9 (MMP9) were inhibited by 15dPGJ2. Moreover GW9662, a speciﬁc
PPARγ antagonist, revealed the participation of other signaling pathways since, in GW9662 presence,
15dPJG2 had a partial effect on the inhibition of inﬂammatory parameters in the acute model of infection.
Accordingly, NF-κB activation was demonstrated, assessing p65 nuclear translocation in the hearts of infected
mice with both T. cruzi strains. Such effect was inhibited after 15dPGJ2 treatment. Our ﬁndings support the
concept that in vivo PPARγ and NF-κB pathways are implicated in the inhibitory effects of 15dPGJ2 on
inﬂammatory mediators at different times depending on whether the infection is caused by the lethal or non-
lethal T. cruzi strain.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Chagas' disease is caused by infection with the protozoan kinetoplas-
tid parasite Trypanosoma cruzi (T. cruzi). This disease is endemic
throughout Central and South America, constituting an important public
health problem. Serious cardiac alterations that characterize chronic
symptomatic Chagas' disease are found in about 30% of infected
individuals, which may develop dilated cardiomyopathy [1].
Differences in cardiac or digestive pathological manifestations
might partially be attributed to particular characteristics of T. cruzi
subpopulations, like lethality [2] tissue tropism [3] and induction of
immune response [4]. Moreover, the evolution of the disease might
depend on the diverse host–parasite relationships. RA and K98 T. cruzi
strains have demonstrated contrasting characteristics [5]. While RA is
highly lethal for mice and replicates actively in the reticuloendothe-
lial system, K98 is a clone isolated from the myotropic CA-I strain
with low lethality and that hardly multiplies in phagocytes [6].raguay 2155, piso 12, Buenos
ax: +54 11 4964 2554.
rights reserved.There are many substantial evidence showing that cardiac tissue, an
important target of T. cruzi, produces marked amounts of pro-inﬂamma-
tory cytokines, chemokines and enzymes including inducible nitric oxide
synthase (NOS2) and metalloproteinases (MMPs), resulting in inﬂam-
mation and cardiac remodeling in response to parasite infection [7–9]. It
has been shown that NOS2 is relevant in the pathogenesis of cardiac
diseases, whereas in Chagas' disease nitric oxide (NO) has been described
as a trypanocidal agent [10–12]. It has also been suggested that the high
output of NO by inﬂammatory cells could lead to heart failure [13].
Moreover, increased MMP production, associated with a sustained
inﬂammatory response, may lead to excessive extracellular matrix
degradation impairing infarct healing and worsening early remodeling,
which in turn causes cardiac rupture [14]. Peroxisome proliferator-
activated receptors (PPARs), members of the steroid hormone receptor
superfamily, are ligand-dependent nuclear transcription factors that have
emerged as regulators of lipidmetabolism aswell as inﬂammation. There
is growing evidence demonstrating the efﬁcacy of PPAR agonists as anti-
inﬂammatorymediators in the heart [15]. For example, the natural ligand
15-Deoxy-Δ12,14 ProstaglandinJ2 (15dPGJ2) has high afﬁnity for PPARγ
and is a potent anti-inﬂammatory molecule. It has been previously
described that 15dPGJ2 can repress some genes in activatedmacrophages
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tumor necrosis factor α (TNF-α), being this repression partially
dependent on PPARγ expression [16,17,9]. Also, it has been reported
that treatment with 15dPGJ2 reduced the inﬂammatory inﬁltrate in the
skeletal muscle at the site of infection and decreased the number of
lymphocytes and neutrophils in the blood during acute phase of T. cruzi
infection [18].
15dPGJ2 is normally present in vivo during the resolution phase of
inﬂammation, suggesting that it may function as a feedback regulator
of the inﬂammatory response [19]. However, little is known about the
role of PPARγ ligands in T. cruzi infection or in Chagas' disease. It has
been described that the major role of PPARγ is the trans-suppression
of inﬂammatory gene activation by negatively interfering with the
nuclear factor kappa B (NF-κB), activator protein 1 (AP-1), signal
transducers and activators of transcription 1 (STAT1) and mitogen-
activated protein kinases (MAPKs) signaling pathways in a DNA-
binding independent manner [20,17].
Here we investigated, in mouse models of infection with different
T. cruzi subpopulations, the role of PPARγ as a modulator of
inﬂammatory mediators in the heart. Treatment with PPARγ natural
ligand, 15dPGJ2, inhibited the inﬂammatory response in terms of
cytokines, NOS2 and MMP expressions in both strains regardless of
the time of infection with each strain. Besides, NF-κB activation in the
heart after RA and K98 infection, and its inhibition by 15dPGJ2
conﬁrms and reveals the participation of both PPARγ and NF-κB in
the modulation of pro-inﬂammatory mechanisms in in vivomodels of
early acute and chronic Chagas' disease.
2. Material and methods
2.1. Mice and infection
Mice used in this study were bred and maintained in the animal
facility of theDepartment ofMicrobiology, Parasitology and Immunology,
School of Medicine, University of Buenos Aires. For the in vivo
experimental model of Chagas' disease, 8‐week old BALB/c male mice
(8–10 per group) were infected intraperitoneally with 105 bloodstream
trypomastigotes of lethal RA (pantropic/reticulotropic) or the non-lethal
K98 strains of T. cruzi subpopulations as previously described [5]. For
experimentswith RA,micewere sacriﬁced at 6, 12, 20, 24, 36 and 48 h or
at day 10 post infections (p.i.), depending on the experimental protocol.
For K98 experiments, mice were sacriﬁced at 1, 2, 5, 11, 14 or 22 days p.i.
In addition, some mice were treated i.p. with 15dPGJ2 (1 mg/kg)
(Cayman Chemical Co) every 24 h or 12 h (depending on the exper-
imental protocol) for mice infected with RA. K98-infected mice were
treated with 15dPGJ2 (1 mg/kg) every 24 h. For experiments performed
with GW9662 (Sigma-Aldrich Co), mice were treated i.p. 30 min before
15dPGJ2 treatment. All animal protocols were approved by the
Institutional Committee for the Care and Use of Laboratory Animals
(CICUAL), School ofMedicine of the University of Buenos Aires, and are in
accordance with guidelines of the Argentinean National Administration
of Medicines, Food and Medical Technology (ANMAT), Argentinean
National Service of Sanity andAgrifoods Quality (SENASA) and also based
on the US NIH Guide for the Care and Use of Laboratory Animals.
2.2. Parasitemia and mortality
At 5, 8 and 10 days p.i., blood was obtained from RA infected or
infected and 15dPGJ2 treatedmice. Also, at 14, 22 and 50 days p.i. blood
was obtained from K98 infected or 15dPGJ2 treated mice. Parasitemia
was analyzed in infected mice through a small incision at the end of the
tail. Five-fold dilutionswere done in red blood cell lysis buffer (150 mM
NH4Cl, 0.1 mM EDTA, and 10 mM KHCO3, pH 7.4). Parasitemia was
measured in a Neubauer chamber. For survival studies, 2 independent
groups (RA or K98 T. cruzi infected and T. cruzi infected and 15dPGJ2-treated mice) of 8 animals each were followed up daily until different
days after infection.
2.3. Histopathology
Hearts from T. cruzi infected and 15dPGJ2-treated and infected mice
were ﬁxed in formalin and embedded in parafﬁn. Six non-contiguous
sections (5 μm) were cut and stained with hematoxylin–eosin. Cellular
inﬁltrate and the number and size of the amastigote nests were
examined using a Nikon Eclipse E600 microscope (Nikon Inc.). Images
were captured using a Spot RT digital camera. At least thirty random
microscopic ﬁelds (400×) were analyzed in each microscopic section,
using ImageJ analysis software (NIH).
2.4. Quantitative real-time polymerase chain reaction (QRT-PCR)
Total RNA was obtained from heart tissue homogenates using Trizol
reagent (Life Technologies, Inc.). Total RNA was reversed transcribed
using Expand Reverse Transcriptase (Promega Corporation). QRT-PCR
was performed using SYBR Green PCR Kit (PE Applied Biosystems Inc.) in
an Applied Biosystems 7500 sequence detector. Primer sequences were:
NOS2 forward: 5′-CACAGCAATATAGGCTCATCCA-3′, reverse: 5′-GGATTT
CAGCCTCATGGTAAAC-3′; PPARγ forward: 5′-ATCTACACGATGCTGGC-3′,
reverse: 5′-GGATGTCCTCGATGGG-3′; TNF-α forward: 5′-ATGAGCACA
GAAAGCATGATC-3′, reverse: 5′-TACAGGCTTGTCACTCGAATT-3′; IL-6
forward: 5′-TGATGCACTTGCAGAAAACAA-3′, reverse: 5′-GGTCTTGGTC
CTTAGCCACTC-3′. All samples were analyzed in the same run for 18S
rRNA expression for normalization: forward: 5′-AACACGGGAAACCT
CACCC-3′ and reverse: 5′-CCACCAACTAAGAACGGCCA-3′. PCR parame-
ters were 50 °C for 2 min, 94 °C for 2 min, and 40 cycles of 94 °C for 30 s,
60 °C (for TNF-α, NOS2 and 18S rRNA) or 54 °C (for IL-6 and PPARγ) for
1 min. Quantiﬁcation was calculated using the comparative threshold
cycle (Ct) method and efﬁciency of the RT reaction (relative quantity,
2−ΔΔCt). The replicates were then averaged and fold induction was
determined, considering the value at zero time as 1 [21].
2.5. Measurement of IL-10 production
IL-10 concentrations were measured in mice sera by ELISA method.
The ELISA sets were IL-10 (BDOptEIA), and procedureswere performed
according to themanufacturer's instructions. The reactionwas detected
by peroxidase-conjugated Streptavidin followed by a substrate mixture
that contained hydrogen peroxide as a substrate and ABTS (Sigma) as a
chromogen. The absorbance measured at 405 nm was compared with
the standard curve of IL-10.
2.6. Preparation of cytosolic, nuclear and total protein extracts for
Western blot
Heart tissues (100 mg) were homogenized with 500 μl of buffer A
(10 mmol/l HEPES; pH 7.9, 1 mmol/l EDTA, 1 mmol/l EGTA, 10 mmol/l
KCl, 1 mmol/l DTT, 0.5 mmol/l phenylmethyl-sulfonyl ﬂuoride,
40 μg/ml leupeptin, 2 μg/ml tosyl-lysyl-chloromethane, 5 mmol/l
NaF, 1 mmol/l NaVO4, 10 mmol/l Na2MoO4), and NP-40 was added
to reach 0.5% (vol/vol). After 15 min at 4 °C, the tubes were gently
vortexed for 10 s, and cytosolic extracts were collected by centrifu-
gation at 13,000 g for 30 s. The supernatants were stored at −80 °C
(cytosolic extracts) and heart pellets were resuspended in 300 μl
buffer A supplemented with 20% (v/v) glycerol and 0.4 M KCl, and
mixed for 30 min at 4 °C. Nuclear proteins were obtained by
centrifugation at 13,000 g for 5 min, and aliquots of the supernatant
(nuclear extracts) were stored at−80 °C.
Total protein extracts were obtained after washing the hearts with
PBS and adding 500 μl of OGP (Sigma-Aldrich Co) lysis buffer. Then,
the tubes were kept on ice for 30 min with swirling and the samples
were centrifuged at 7000 g at 4 °C for 10 min. The supernatant was
Table 1
Parasitemia and mice survival after infection with RA and K98 Trypanosoma cruzi
subpopulations. Evaluation of parasitemia and mortality rates in mice infected with RA
and K98, at different days post infection. Results are means±SE from at least three
independent experiments. ND: not detected; +: less than 104 parasites/ml.
Experimental
groups
T. cruzi (RA) T. cruzi (K98)
Day 5 8 10 15 11 14 22 50
Parasites/ml
(×106)
0.67±
0.017
1.5±
0.97
2.2±
0.16
− ND + 0.02±
0.08
1.21±
0.34
Survival (%) 100 100 60 0 100 100 100 100
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of sera and heart tissue of mice were determined by the Bradford
method using the Bio-Rad Protein Assay (Bio-Rad CA., USA) reagent
and bovine serum albumin (BSA) (Sigma-Aldrich Co.) as a standard
[12].
2.7. Zymography
MMP activity in mice sera was measured using gelatin in-gel
zymography. Mice sera were subjected to a 7.5% SDS-PAGE, in which
1 mg/ml gelatin (type A from porcine skin; Sigma Aldrich Co.) was
incorporated. Following electrophoresis, gels were washed in 30% Triton
X-100 for 60 min to remove SDS. Then, the gelswere incubated in 50 mM
Tris buffer pH 7.4, containing 0.15 mMNaCl and 30 mMCaCl2, for 36 h at
37 °C. Gels were stained with Coomassie Brilliant Blue R and then
distained with a mixture of 10% acetic acid and 30% methanol in water.
The areas of proteolytic activity appeared as negatively stained bands
in the dark background. Identiﬁcation of MMPs was based on their
molecular weights. A positive internal control (activated peritoneal
macrophages) was run in each gel to allow the standardization of the
results obtained in the different zymograms. After destaining, the clear
regions representing MMP activity were quantiﬁed by densitometry
using the ImageJ program developed at the NIH (USA).
2.8. Electrophoretic mobility shift assays (EMSA)
The oligonucleotide sequence 5′-TGCTAGGGGGATTTTCCCTCTCTCT
GT-3′, corresponding to the consensus NF-κB binding site (nucleotides
−978 to −952) of the murine NOS2 promoter, was annealed with the
complementary sequence by incubation for 5 min at 85 °C in 10 mmol/l
Tris–HCl, pH 8.0, 50 mmol/l NaCl, 10 mmol/l MgCl2, and 1 mmol/l
dithiothreitol. Aliquots (100 ng)were end-labeledwith Klenow fragment
of DNA polymerase I fragment in the presence of 50 mCi of [α-32P] dCTP
and the other unlabeled dNTPs in a ﬁnal volume of 50 ml. DNA probe
(5×104 dpm) was used for each binding assay: 5 μg of nuclear heart
proteinswas incubated for 15 min at 4 °Cwith the probe andwith 1 μg of
poly (dI–dC), 5% glycerol, 1 mmol/l EDTA, 10 mmol/l KCl, 5 mmol/l
MgCl2, 1 mmol/l dithiothreitol, and 10 mmol/l Tris–HCl (pH 7.8) in a ﬁnal
volume of 20 μl. The DNA–protein complexes were separated on native
6%polyacrylamide gels in 0.5% Tris–borate–EDTAbuffer. Supershift assays
were carried out after the addition of the antibody against NF-κB protein
(p65) (0.5 μg) to the binding reaction and incubation for 1 h at 4 °C before
the addition of the probe. Analysis of competition with unlabeled
oligonucleotideswasperformedusing a 20-fold excess of double stranded
DNA in the binding reaction and adding the nuclear extracts as the last
step in the binding assay. Unrelated competitor oligonucleotide AP-1
(consensus) corresponding to the AP-1 motif of the albumin promoter,
5′-TTCCAAAGAGTCATCAG-3′was used to ensure band speciﬁcity.
2.9. Statistical analysis
For the in vivo experimental models of Chagas' disease, data were
expressed as means±SE. Survival curves were compared using the
Kaplan–Meier's test. One-way ANOVA was used for the comparison of
NOS2, MMP-2/9, IκB-α and p65 Western-blot band intensity of controls,
T. cruzi-infected and T. cruzi-infected 15dPGJ2-treated mice. Data were
expressed as means±SD. Differences were considered signiﬁcant at
pb0.05. All analyses were performed with Prism Software (GraphPad
version 5.01).
3. Results
3.1. Course of infection
BALB/c mice were infected with 105 trypomastigotes of RA or K98 T.
cruzi strains via intraperitoneal route. The parasitemia levels, assessedfrom the 5th day p.i. revealed that the mice infected with virulent and
lethal T. cruzi strain, RA, had a signiﬁcant increase of blood parasites on
days 5 and 8 post infection with maximum number of parasites on day
10 (Table 1).While, inmice infectedwith the non-lethal strain, K98, the
parasitemia was evident and quantiﬁable at day 22 p.i., and on day 50
the number of parasites increased signiﬁcantly (Table 1). After reaching
maximumvalue (45–50 dpi) a plateau developed that slowly decreased
over time. Consistently with parasitemia levels, mice infected with RA
strain did not survive at day 15 p.i. whereas K98 non-lethal strain
infected mice showed 100% survival as illustrated in Table 1.
3.2. Pro-inﬂammatory enzymes are inhibited by 15dPGJ2 treatment in
the hearts of T. cruzi infected mice
It has been reported that PPARγ ligands are implicated in the control
of inﬂammatory response. However, little is known about the role of
PPARγ in the course of T. cruzi infection. One of the ﬁrst aims of our
work was to analyze 15dPGJ2 effects on the expression of representa-
tive inﬂammatory enzymes like NOS2 and MMP-2/9 in the acute and
chronic experimental mouse models of T. cruzi infection. Therefore,
mice were treated with 15dPGJ2 (1 mg/kg) every 24 h, since the ﬁrst
day after infection and until the day before sacriﬁce, with minor
modiﬁcations as described previously by Kaplan et al. [22]. Fig. 1 shows
the NOS2 expression in the heart at day 10 p.i. with RA strain whereas
15dPGJ2 treatment inhibits both NOS2 mRNA and protein expressions
in the hearts (Fig. 1A and B). On the other hand, the hearts of mice
infected with K98 strain required 22 days p.i. to express NOS2 and
15dPGJ2 treatment could also inhibit mRNA and protein expressions
(Fig. 1C and D).
MMP-2/9 expressions were evaluated in the heart by Western blot
and their activities were analyzed by gelatin zymography in sera of RA
and K98 infected mice. Fig. 2A and B shows that MMP-2 protein
expression and activity appear and increase at day 10 in mice infected
with the acute strain of T. cruzi compared with uninfected mice.
Nevertheless, MMP-9 was undetectable in this model of acute infection
(Fig. 2A). However, when infected mice were treated everyday with
15dPGJ2, we observed a signiﬁcant decrease in cardiac enzyme
expression and in sera activity, compared to untreated infected mice.
Interestingly, when MMPs were studied in mice infected with K98 T.
cruzi strain,MMP-2 expressionwas not detected (Fig. 2C), showing that
MMP-2 is not a typical marker in a chronic model of inﬂammation.
However, we could determineMMP-9 expression and activity at 22 dpi
as shown in Fig. 2C and D. These results are in agreement with times of
increased expression of both enzymes reported by other authors [23].
Furthermore in both groups of mice treated daily with 15dPGJ2, MMP-
2/9 expressions and activities were diminished (Fig. 2).
3.3. Role of 15dPGJ2 on cytokine expression in T. cruzi infected mice
Taking into account that 15dPGJ2 treatment inhibited inﬂamma-
tory enzyme expression, we speculate about the possibility that it can
also inhibit the expression of inﬂammatory cytokines.
Fig. 1. 15dPGJ2 treatment regulates NOS2 expression in the hearts of mice infected with RA and K98 Trypanosoma cruzi subpopulations. NOS2 mRNA levels were analyzed by QRT-
PCR in the heart extracts of infected mice or infected and 15dPGJ2-treated (1 mg/kg) at days 10 (RA) and 22 p.i. (K98) (A and C, respectively). The QRT-PCR results were normalized
against 18S rRNA. NOS2 expression was determined in the same conditions as in A and C byWestern blot with a speciﬁc antibody. Protein levels were normalized against α-actin (B
and D). For A and C, results show the mean±SD (n=3). For B and D, results show representative experiments out of 3 performed. **pb0.05 vs. Control mice; #pb0.05 vs. T. cruzi
infected mice.
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considerable amounts of TNF-α mRNA and IL-6 mRNA measured
by QRT-PCR, with a signiﬁcant peak 24 h after infection with RA
and 22 days after K98 infection. Moreover, we found that these
cytokines were signiﬁcantly diminished in the groups of mice pre-
treated with 15dPGJ2, as we have seen in the study of inﬂammatory
enzyme expressions (Figs. 1 and 2). As a consequence, we also
evaluated the capacity of 15dPGJ2 to induce a modulatory immune
response by measuring IL-10 levels in sera of mice infected with both
T. cruzi strains. Fig. 4A and B shows a signiﬁcant increase of IL-10 levels
in infected mice pre-treated with 15dPGJ2 in comparison with
untreated infected mice.
On the other hand, 15dPGJ2 treatment slightly increased parasitemia
levels in RA infected mice as shown in Fig. 5A. However, the mortality
rates remained unchanged (Fig. 5B). 15dPGJ2 treatment in K98 infected
mice did not modify the parasitemia at days 22 and 50 p.i. As expected,
treatment with PPARγ ligand did not modify the survival rates of K98-
infectedmice.Moreover, PPARγ ligand-treatedmice showed signiﬁcantly
higher amastigote nest sizes than untreated mice both for RA (Fig. 5C)
and K98 (Fig. 5D), respectively.
3.4. 15dPGJ2 inhibits NF-κB activation in the hearts of mice infected with
acute and chronic T. cruzi strains
15dPGJ2 is a high-afﬁnity ligand for PPARγ. We have previously
demonstrated that it inhibits the induction of inﬂammatory genes in
both lipopolysaccharide stimulated and in in vitro T. cruzi infected
cardiomyocytes through PPARγ dependent or independent pathways,
like NF-κB [9,17]. To further assess the role of PPARγ in 15dPGJ2 effects
in our in vivo model, we determined PPARγ mRNA expression in thehearts of RA and K98 infected mice, 10 and 22 days after infection,
respectively. Fig. 6A and B shows a signiﬁcant increase in PPARγmRNA
expression in the hearts of infected mice in comparison with those of
uninfected ones. Additionally, mice infected with RA strain were pre-
treated with the speciﬁc and irreversible PPARγ antagonist GW9662,
which partially prevented 15dPGJ2 inhibitory effect on cardiac NOS2
expression, MMP-2 serum activity and the increase in parasitemia of
infected mice (Fig. 7).
Therefore, we proposed to analyze the mechanism by which
15dPGJ2 inhibited the expression of inﬂammatory mediators in the
acute and chronic in vivo experimental models of Chagas' disease, since
GW9662 partially prevented 15dPGJ2 inhibitory effects. Then, our next
aimwas to determine the possible activation of NF-κB in the hearts of T.
cruzi-infected mice. First, we studied the cytosolic expression and
disappearance of IκBα, anNF-κB inhibitor, in the hearts ofmice infected
with both T. cruzi strains. Fig. 8A shows the NF-κB activation since IκBα
disappeared in cytosolic heart extracts at 24 h and 36 h after infection
with RA T. cruzi strain. These results were conﬁrmed by EMSA assays,
showing activation of p65–NF-κB subunit 48 h after infection in nuclear
extracts of heart tissue (Fig. 8B). Anti-p65 caused a supershift of nuclear
heart extracts after 48 h of infection and excess of unlabeled
oligonucleotide as well as an unrelated competitor oligonucleotide
(AP-1) was used to ensure band speciﬁcity (data not shown).
Secondly, we analyzed NF-κB activation in the heart extracts of K98
infected mice. We observed, contrasting with mice infected with the RA
strain, that those infected with K98 require longer time for NF-κB
activation. Fig. 8C shows IκBα disappearance only after 11 days post-
infection. EMSA assays are consistent with these results, since NF-κB
activation is demonstrated by p65–NF-κB subunit appearance in nuclear
extracts 11 days after K98 infection (Fig. 8D).
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IκBα, we asked whether the effects of 15dPGJ2 were exerted through
NF-κB pathway in addition to PPARγ. Therefore, RA and K98 infected
mice were treated with 15dPGJ2. p65–NF-κB could not translocate to
the nucleus as shown by EMSA assay (Fig. 9), conﬁrming PPARγ
independent pathway on 15dPGJ2 effects in T. cruzi infected mice.
4. Discussion
In this study we investigated the ability of 15dPGJ2 to modulate in
vivo pro-inﬂammatory mediators in the hearts of T. cruzi infected mice
as well as the contribution of PPARγ-independent mechanisms to this
regulation. An acute lethal and a chronic non-lethal model of infection
were employed. Both infection models show the expected behavior
with peaks of parasitemia at 10 dpi (RA) and reaching the maximum
level of a plateau at 45–50 dpi (K98), as described by Pino Martínez
2011 [MSC thesis] for BALB/c mice and Celentano et al. for inbred C3H/
HeN mice and outbred Rockland mice [24]. Although the ability of
15dPGJ2 to modulate the inﬂammatory response has been described in
a number of pathological situations, the details of its whole mechanism
remain largely unidentiﬁed. This work focuses for the ﬁrst time on the
role of the natural PPARγ ligand in in vivo experimental models of T.
cruzi infection. Our data show that 15dPGJ2 inhibits the expression andFig. 2. Inhibition of MMP-2 and MMP-9 expressions and activity by 15dPGJ2 treatment in mi
Western blot in the heart extracts at day 10 post infection with RA and at day 22 for K98 in
were used and protein levels were normalized against α-actin (A and C, respectively). Sera
by zymography for MMP-2 and MMP-9 activities in the same conditions as in A and C (B and
**pb0.05 vs. Control mice; #pb0.05 vs. T. cruzi infected mice.activity of pro-inﬂammatory enzymes such as NOS2 and MMP-2 and it
also modulates cytokine expression. Moreover, increased parasitemia
associatedwith 15dPGJ2 treatment in the hearts of T. cruzi infectedmice
probably reﬂects NOS2 inhibition and the consequent diminished NO
levels. Regarding the role of NO in the control of parasitemultiplication in
vivo Cummings and Tarleton [25] showed that NOS2-KO mice may
compensate for the absence of NO production with the upregulation of
cytokines important in immune control of T. cruzi infection. In the same
line Marinho et al. [26] using a non-lethal T. cruzi strain showed that
NOS2-KOmice are also able to control parasitemia and tissue parasitism.
The explanation for these controversial results may lie in the genetic
differences in the parasite strains and mice used.
We have previously shown that 15dPGJ2 is a potent modulator of
the inﬂammatory process, through PPARγ dependent and indepen-
dent pathways in cultures of T. cruzi infected neonatal cardiomyo-
cytes [9]. In the present study we also determined the capacity of
PPARγ natural ligand to exert anti-inﬂammatory effects by inhibiting
the expression of inﬂammatory cytokines like TNF-α and IL-6 or
enzymes like NOS2 and MMP-2/9 in RA and K98 infected mice. Of
note, NO regulation has an important role, since it is required for
intracellular killing of T. cruzi, but its synthesis in excess may damage
the myocardium [7,8]. Different studies underline the importance of
NO in the control of intracellular parasite multiplication duringce infected with RA or K98 T. cruzi subpopulations. MMP expression was determined by
fection, or in 15dPGJ2-treated (1 mg/kg) mice. MMP-2 and MMP-9 speciﬁc antibodies
from RA- or K98-infected or T. cruzi-infected and 15dPGJ2‐treated mice were evaluated
D). For A, B, C and D results show representative experiments out of three performed.
Fig. 3. Regulation of inﬂammatory cytokine expression by 15dPGJ2 treatment in the hearts of T. cruzi-infected mice. Mice were infected with RA T. cruzi subpopulation for 36 h or
with K98 subpopulation for 22 days. QRT-PCR assays were performed in infected or infected and 15dPGJ2-treated (1 mg/kg) mice and TNF-α (A and C) and IL-6 (B and D) mRNA
expressions were analyzed. The results were normalized against 18S rRNA. Results show representative experiments out of three performed. **pb0.05, vs. Control mice; #pb0.05
vs. T. cruzi infected mice.
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acute infection in comparison with infected wild type mice [27].
Several factors contribute to chagasic cardiomyopathy and tissue
damage, mainly including parasite persistence in the heart tissue
[28]. The MMP family may also contribute to the development of
chagasic cardiomyopathy, facilitating parasitic infection. In this
regard, mice treated with an MMP inhibitor showed signiﬁcantly
decreased heart inﬂammation [29]. We have previously studied MMP
cardiac expression by means of two different experimental models,
lipopolysaccharide challenge and T. cruzi infection in vitro, conﬁrming
that cardiomyocytes were able to express MMP-9 and MMP-2
[9,17,21]. The fact that MMP9 but not MMP2 is detected in the heart
extracts of K98-infected mice suggests that the last one may play aFig. 4. Effect of 15dPGJ2 treatment on IL-10 expression in sera of RA and K98 infected mi
15dPGJ2-treated (1 mg/kg) mice at day 10 post infection (A). Sera from K98 infected or
production was detected (B). Results are the means±SD from three independent experimrole at stages when heart damage is more severe. Of note, histological
examination showed amastigote nests but scarce inﬂammatory reac-
tion and slight necrosis. Moreover, our results of acute and chronic in
vivo models conﬁrm different reports showing that MMP-2 has rapid
effects in regulating diverse early cellular functions independently of its
action on the extracellularmatrix [30] and also causes acutemyocardial
dysfunction after ischemia–reperfusion injury [31]. Furthermore, we
found that pre-treatment of isolated cardiomyocytes with 15dPGJ2
inhibited MMP-9 and MMP-2 mRNA expressions as well as their
gelatinolytic activity, being the regulation by 15dPGJ2 mediated
through transcriptional mechanisms [21,17,9]. In the present work we
conﬁrm that exogenous 15dPGJ2 regulates MMP-2/9 expressions and
activity in in vivomouse models of T. cruzi infection.ce. IL-10 production was measured by ELISA in sera from RA infected or infected and
infected and 15dPGJ2 treated mice were collected at day 22 post infection and IL-10
ents. **pb0.05, vs. Control mice; #pb0.05 vs. T. cruzi infected mice.
Fig. 5.Mice parasitemia, survival and heart parasitism after RA and K98 Trypanosoma cruzi subpopulation infection. Parasitemia was analyzed until day 10 of infection with RA and
until day 50 of infection with K98 in 15dPGJ2 (1 mg/kg) treated (open symbols) or untreated (ﬁlled symbols) mice (A). Mice were infected and treated as in A and survival rates
were analyzed by Kaplan–Meier's test (B). Cardiac parasitism was analyzed in histological sections of the hearts of infected and 15dPGJ2-treated or untreated mice stained with
hematoxylin–eosin. Bar graph: area of amastigote nests±SD (μm2), #pb0.02. Arrows show amastigote nests. Bar: 50 μm. Micrographs (400×) are representative of 3 experiments
out of 8 mice per group (C and D). For A, results are the means±SE (n=6) and for B results are survival percentage from at least three independent experiments.
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infectedmice. The number of bloodstream trypomastigoteswas higher in
treated than in untreated infected mice. Besides, 15dPGJ2 treatment
increased heart parasitism in both models. While mobilization of
inﬂammatory cells was observed as perivascular inﬁltrates as well as
some interstitial inﬁltrates (data not shown), infected cells (amastigote
nests) were devoid of surrounding inﬂammatory reaction in bothmodels
(Fig. 5C and D). This might suggest that 15dPGJ somehow increases
intracellular parasitism. In fact, in vitro cultured neonatal cardiomyocytes
infected with the RA strain of T. cruzi show increased parasitism upon
treatment with 15dPGJ2 in a model where inﬂammatory cells are absent
[9]. Moreover, no differences in the mortality between experimental
groups were observed. The balance between downregulation of expres-
sion of pro-inﬂammatory cytokines and upregulation of IL-10 could allow
mouse survival. Downregulation in the levels of systemic cytokines byFig. 6. PPARγ expression after Trypanosoma cruzi infection. PPARγ mRNA expression was a
infection (A) and at day 22 post infection (B), respectively. The results were normalized ag15dPGJ2 has been described in models of inﬂammatory response [32].
Gallardo-Soler et al. suggest in Leishmania major infection model, that
arginase induction by PPAR ligands changes macrophage functions to a
more permissive stage that is suitable for parasite growth. This activation
status closely resembles the one triggered by Th2 response, since it is
comparable to that achieved in the presence of IL-4. Inhibition of parasite
growth by PPAR antagonists demonstrates that this nuclear receptor is a
key factor in macrophage alternative activation [33] consistent with
previous works by Kopf and colleagues in which dyslipidemia inhibited
protective Th1-type immunity and increased host susceptibility to L.
major infection [34].Moreover, Cuervo and colleagueshavedemonstrated
that Th2 cytokines induce arginase expression, whichmay inﬂuence host
and parasite cell survival but which might also downregulate the
deleterious effects triggered by NOS2, in the heart tissue during in vivo
acute T. cruzi infection of BALB/c and C57BL/6 mice [35].nalyzed by QRT-PCR in the hearts of control, RA- or K98-infected mice at day 10 post
ainst 18S rRNA. Results show the mean±SD (n=4). **pb0.05, vs. Control mice.
Fig. 7. PPARγ participation in 15dPGJ2 effects on NOS2 expression, MMP-2 activity and parasitemia. Mice were infected and treated daily with the PPARγ antagonist GW9662
(1 mg/kg) and 15dPGJ2 (1 mg/kg), 30 min later. At day 10 post-infection the heart extracts were obtained and Western blot analyses were done for NOS2 expression. Protein levels
were normalized against α-actin (A). Mice were treated as in (A) and sera were subjected to gelatin zymography to detect MMP-2 activity (B). Mice were treated as in (A) and the
parasitemia values were evaluated at 10 day post-infection (C). For A and B, results show representative experiments out of 3 performed. For C, results are the means±SE (n=6).
**pb0.05 vs. Control mice; #pb0.05 vs. T. cruzi infected mice. ^pb0.05 vs. T. cruzi+15dPGJ2 infected mice.
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treatment could be explained by the upregulation of IL-10 levels in
15dPGJ2-treated RA and K98 infected mice, a cytokine mainly secreted
by Treg, B cells and some Th2 cells. The levels of serum IL-10 are several
times lower in mice infected with non-lethal strain, K98, with respect
to those infectedwith RA. However, itmust be noted that the levels of IL-
10 in 15dPGJ2-treated to untreatedmice ratio remain approximately the
same (4.5–5 times) for both parasite strains. Besides, Carrera-Silva et al.
[36] showed that pro-inﬂammatory cytokines were effectively coun-
tered by IL10 as well as TGF-β regulatory cytokines. Therefore, TGF-β
might be playing a compensatory role for regulation in the case of K98,
which produces signiﬁcantly lower absolute levels of IL-10 than RA.
In this work we found increased levels of PPARγ mRNA expression
in the hearts of infected mice compared to uninfected ones. It has also
been demonstrated that PPARγ expression is increased in the airway
mucosa of asthmatic patients when compared with healthy subjects
[37]. Recent evidence in amousemodel of leishmaniasis suggested that
PPARγ expression was not modiﬁed in the liver but it was increased in
the spleen upon infection [38]. In fact, PPARγ levels in inﬂammatory
models are controversial since during the cardiovascular hypodynamic
phase of septic shock PPARγ expression decreases in endothelial and
aortic vascular smooth muscle cells [39]. In order to evaluate the
implication of increased PPARγ in 15dPGJ2 effects, RA infected mice
were pre-treated with a speciﬁc PPARγ antagonist, GW9662, revealing
partial reversion of 15dPGJ2 inhibitory effects onNOS2 heart expression
and NO production. Also, GW9662 prevented the inhibitory effect of
PPARγ natural ligand on MMP-2 activity in serum of infected mice.
Herein we have demonstrated NF-κB activation in the heart after
mice infection and, also, the inhibition of this pathway by 15dPGJ2 pre-treatment. In previous studies we observed that 15dPGJ2 exerts anti-
inﬂammatory effects in LPS or T. cruzi‐stimulated cardiac cells bymeans
of PPARγ‐dependent and ‐independent mechanisms involving tran-
scription factors like NF-κB [17,9]. Moreover, several authors have
demonstrated that 15dPGJ2 exerts a strong anti-inﬂammatory effect by
attenuating the expression of pro-inﬂammatory mediators in activated
monocytes/macrophages. This effect is mainly exerted through the
inhibition of NF-κB-dependent transcription of inﬂammatory genes
[16,40].
Taken together, our data suggest that 15dPGJ2 downregulates
inﬂammatory enzymes and cytokines after T. cruzi infection. Despite
the increased parasitism, probably due to decrease in NO levels, its
effect may be beneﬁcial, reducing the detrimental effects of the
inﬂammatory response. The fact that GW9662 partially restored NOS2
and MMP-2 levels and activity after 15dPGJ2 treatment, strongly
suggests that the participation of PPARγ‐independent signaling path-
ways is operative in vivo. In summary, the regulation of the heart's
inﬂammatory response by the PPARγ natural ligand in acute and
chronic Chagas' heart disease through PPARγ‐dependent and NF-κB
pathways opens new avenues to putative pharmacological treatments.Acknowledgements
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